Stille
Stille at a glance
Stille is a well-established pioneer in the development and manufacturing of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high- precision procedures.
Headquartered in Torshälla, Sweden, and listed on Nasdaq First North Stockholm, with c. 180 FTEs and
activities in 70+ markets through a broad network of distributors.
Stille facts
MedTech
January 2024
Eskilstuna, Sweden
Ulrik Berthelsen (CEO)
Niklas Tyrén (CFO)
Victor Steien
Fredrik Strömholm
Frederikke Beck
Paula Johansson
182
Investment Thesis
- Sizeable addressable market and growing at 6-7% p.a. in sticky niches for premium surgical instruments
- Stille is well positioned to continue outgrowing the market, leveraging its over-exposure to faster growing segments (cardio and surgery), its strong brand, value proposition, and distribution network
- Scope to drive profitable growth through increased direct sales efforts in selected key markets / repatriate distributor margins and through continued streamlining and automation of resource intensive steps of the production process
- Fehling Instruments comes with a highly complementary product offering, enlarged commercial infrastructure paving the way for cross-selling opportunities, and a strengthened R&D function for the instruments business
UN SDG Goals
Other portfolio companies
Oticon Medical
Oticon Medical is a global hearing healthcare company specializing in bone-anchored hearing solutions (BAHS), a niche segment addressing conductive hearing loss.
Qufora
Qufora is a fast-growing Danish medical technology product company with focus on transanal irrigation (“TAI”) products and collecting devices
Avia Pharma
Avia is a leading North European OTC/Rx platform